Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine
Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
| Trade Name | Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine |
| Generic | Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen |
| Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen Other Names | Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine |
| Type | |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine
